Article Details
Retrieved on: 2018-04-25 14:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>In the first quarter, Roche closed two acquisitions: <b>Flatiron Health</b> and Ignyta, Inc. Roche acquired <b>Flatiron Health</b> to accelerate development and delivery of breakthrough medicines for patients with cancer. <b>Flatiron Health</b> will continue its operations as a separate legal entity. Ignyta, Inc., now part of ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here